Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G/A - Relmada Therapeutics, Inc. | StockGist | StockGist

Companies
RLMD
SCHEDULE 13G/A

Home Top Movers Companies Concepts

Home Filings RLMDSCHEDULE 13G/A

SCHEDULE 13G/A

Beneficial Ownership

Amendment

Relmada Therapeutics, Inc.

Filed Feb 17, 2026

Accepted Feb 16, 2026, 7:00 PM ET

CIK 0001553643

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

Shares Owned

7,395,510

Reporting Person

RELMADA THERAPEUTICS, INC.

Person Type

PN

CUSIP: 75955J402

Amendment History

2 filings

SCHEDULE 13G
Original
Feb 17, 20260000902664-26-001027
SCHEDULE 13G/A
Amendment 1
Latest
Viewing
Feb 17, 20260002050709-26-000007

Key Facts

Shares Owned

7,395,510

Recent Filings

Relmada Therapeutics, Inc.2 weeks ago

Relmada Therapeutics, Inc.2 weeks ago

Relmada Therapeutics, Inc.3 weeks ago

Relmada Therapeutics, Inc.1 months ago

Relmada Therapeutics, Inc.1 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice